Several clinical and non-clinical risk factors for stroke in patients with atrial fibrillation have been identified, and clinically useful classification schemes have been developed to facilitate risk stratification in these patients.
Both a history of hypertension and systolic blood pressure >160 mmHg have been shown to be consistent independent risk factors for stroke, resulting in a twofold increase in stroke risk.
The European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation - A Brief Summary
Citation:
Arrhythmia & Electrophysiology Review 2013;2(2):115-9
648
0
The Role of Continuous Monitoring in Atrial Fibrillation Management
Citation:
Arrhythmia & Electrophysiology Review 2014;3(1):48-50
2426
0
The Potential Role of Edoxaban in Stroke Prevention Guidelines
Citation:
Arrhythmia & Electrophysiology Review 2014;3(1):40-3
1085
0
Anticoagulation in Atrial Fibrillation
Citation:
Arrhythmia & Electrophysiology Review 2012;1(1):12–6
339
0
